Free Trial
NASDAQ:BWAY

Brainsway (BWAY) Stock Price, News & Analysis

Brainsway logo
$15.34 +0.08 (+0.52%)
Closing price 04:00 PM Eastern
Extended Trading
$15.31 -0.03 (-0.20%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Brainsway Stock (NASDAQ:BWAY)

Key Stats

Today's Range
$14.70
$15.49
50-Day Range
$10.91
$15.90
52-Week Range
$7.06
$16.00
Volume
114,921 shs
Average Volume
55,991 shs
Market Capitalization
$289.93 million
P/E Ratio
59.00
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Brainsway Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
61st Percentile Overall Score

BWAY MarketRank™: 

Brainsway scored higher than 61% of companies evaluated by MarketBeat, and ranked 418th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Brainsway has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Brainsway has only been the subject of 2 research reports in the past 90 days.

  • Read more about Brainsway's stock forecast and price target.
  • Earnings Growth

    Earnings for Brainsway are expected to grow by 100.00% in the coming year, from $0.08 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Brainsway is 58.85, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.67.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Brainsway is 58.85, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.76.

  • Price to Book Value per Share Ratio

    Brainsway has a P/B Ratio of 4.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Brainsway's valuation and earnings.
  • Percentage of Shares Shorted

    0.54% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 25.27%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Brainsway does not currently pay a dividend.

  • Dividend Growth

    Brainsway does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.54% of the float of Brainsway has been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 25.27%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Brainsway has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Brainsway this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for BWAY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Brainsway to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Brainsway insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Brainsway is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.11% of the stock of Brainsway is held by institutions.

  • Read more about Brainsway's insider trading history.
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brainsway and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BWAY Stock News Headlines

HC Wainwright Reaffirms "Buy" Rating for Brainsway (NASDAQ:BWAY)
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensuring wealth is passed on according to your wishes. Trusts may also provide shielding from creditors and lawsuits while offering potential tax advantages—especially with estate tax thresholds set to decrease in 2026. If you’re considering whether a family trust is right for you, speaking with a fiduciary financial advisor can help you decide the best path forward. We’ve created a free tool that matches you with vetted advisors in your area—each legally bound to act in your best interest.tc pixel
BrainsWay Falters on New Investment
Q3 Earnings Forecast for Brainsway Issued By Northland Capmk
See More Headlines

BWAY Stock Analysis - Frequently Asked Questions

Brainsway's stock was trading at $9.43 on January 1st, 2025. Since then, BWAY shares have increased by 62.2% and is now trading at $15.30.

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) issued its quarterly earnings results on Wednesday, August, 13th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.07 by $0.03. The business earned $12.63 million during the quarter, compared to the consensus estimate of $12.34 million. Brainsway had a trailing twelve-month return on equity of 8.97% and a net margin of 11.60%.
Read the conference call transcript
.

Brainsway (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at $11.94 per share. Cantor acted as the underwriter for the IPO.

Top institutional shareholders of Brainsway include Phoenix Financial Ltd. (1.92%), Acadian Asset Management LLC (1.77%), ARK Investment Management LLC (1.06%) and Huntleigh Advisors Inc. (0.41%).

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brainsway investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP).

Company Calendar

Last Earnings
8/13/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BWAY
CIK
1505065
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$17.00
Potential Upside/Downside
+18.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
58.66
Forward P/E Ratio
190.63
P/E Growth
N/A
Net Income
$2.92 million
Net Margins
11.60%
Pretax Margin
12.66%
Return on Equity
8.97%
Return on Assets
5.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.51
Quick Ratio
3.34

Sales & Book Value

Annual Sales
$41.02 million
Price / Sales
7.03
Cash Flow
$0.24 per share
Price / Cash Flow
63.76
Book Value
$3.60 per share
Price / Book
4.24

Miscellaneous

Outstanding Shares
18,900,000
Free Float
15,311,000
Market Cap
$288.23 million
Optionable
Not Optionable
Beta
1.42

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:BWAY) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners